Physician

Adil Omar Katabay, MD

According to 2025 Medicare claims, Adil Katabay, MD (NPI: 1346204039) practices interventional pain management (ipm), with the plurality of this provider's patient population coming from Marion, OH. This provider's primary affiliated billing organization is MARION PAIN CENTER, LLC (NPI: 1326360082; TIN: 271901918) and primary practice location at 43302-6461.

Katabay's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 276 traditional Medicare patients, billed 15,539 HCPCS/CPT codes, and received $313,863 in Medicare payments. The top billing code was G0483 (Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms). Part D data shows 18,320 prescription claims across 1,034 beneficiaries totaling $1,052,636 in drug costs, led by Xtampza Er (Oxycodone Myristate). DME data shows 30 claims. Open Payments data shows 23 records totaling $2,174. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $396,888 to $1,052,636. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $2,077 to $1,791.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	265	9,335	$414,920
2016	378	14,224	$612,883
2017	391	16,271	$700,536
2018	382	15,113	$789,746
2019	356	12,899	$714,307
2020	370	9,450	$519,902
2021	318	11,198	$593,290
2022	301	8,306	$471,475
2023	276	7,543	$402,036
2024	276	15,539	$313,863

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	355	6,795	$396,888
2016	411	7,352	$384,016
2017	481	8,476	$591,991
2018	528	9,218	$716,516
2019	526	9,130	$844,621
2020	682	11,587	$1,034,312
2021	679	13,016	$1,074,547
2022	792	15,964	$1,285,380
2023	908	18,555	$1,314,359
2024	1,034	18,320	$1,052,636

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	24	53	$2,077
2016	13	13	$12,642
2017	79	91	$76,638
2018	26	26	$25,278
2019	21	21	$21,177
2020	23	23	$23,622
2021	59	59	$42,914
2022	N/R	16	$593
2023	12	113	$8,101
2024	N/R	30	$1,470

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0483	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms	230	521	$240
93923	Complete ultrasound study of arm and leg arteries	135	294	$72
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	228	603	$45
80305	Testing for presence of drug, read by direct observation	234	534	$12
93040	Electrocardiogram (ecg) 1 to 3 leads with review by physician	135	147	$7

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xtampza Er	Oxycodone Myristate	464	13,737	$321,537
Oxycontin	Oxycodone Hcl	244	7,135	$123,050
Relistor	Methylnaltrexone Bromide	43	1,276	$117,852
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	3,633	107,944	$110,841
Belbuca	Buprenorphine Hcl	41	976	$31,280

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0745	Neuromuscular stimulator, electronic shock unit	Y	N/R	30	$1,470

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	23	$2,174	Lumenis BE inc
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Adil Omar Katabay, MD?

Tedicare shows public-source Medicare data for Adil Omar Katabay, MD (NPI 1346204039), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adil Omar Katabay, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Adil Omar Katabay, MD?

Adil Omar Katabay, MD is linked to MARION PAIN CENTER, LLC (billing NPI 1326360082) in the available physician profile data.

Does Adil Omar Katabay, MD have Open Payments data?

Adil Omar Katabay, MD has 23 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.